Annual Accounts Receivable
$40.18 M
+$2.61 M+6.94%
31 December 2023
Summary:
ProPhase Labs annual accounts receivable is currently $40.18 million, with the most recent change of +$2.61 million (+6.94%) on 31 December 2023. During the last 3 years, it has risen by +$38.20 million (+1934.28%). PRPH annual accounts receivable is now at all-time high.PRPH Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$31.64 M
-$1.30 M-3.94%
30 September 2024
Summary:
ProPhase Labs quarterly accounts receivable is currently $31.64 million, with the most recent change of -$1.30 million (-3.94%) on 30 September 2024. Over the past year, it has dropped by -$7.00 million (-18.13%). PRPH quarterly accounts receivable is now -21.25% below its all-time high of $40.18 million, reached on 31 December 2023.PRPH Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRPH Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.9% | -18.1% |
| 3 y3 years | +1934.3% | +196.2% |
| 5 y5 years | +1253.7% | +2033.4% |
PRPH Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1934.3% | -21.3% | +196.2% |
| 5 y | 5 years | at high | +1934.3% | -21.3% | +2508.2% |
| alltime | all time | at high | +1965.7% | -21.3% | >+9999.0% |
ProPhase Labs Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $31.64 M(-3.9%) |
| June 2024 | - | $32.94 M(-6.2%) |
| Mar 2024 | - | $35.12 M(-12.6%) |
| Dec 2023 | $40.18 M(+6.9%) | $40.18 M(+4.0%) |
| Sept 2023 | - | $38.64 M(+0.2%) |
| June 2023 | - | $38.57 M(+1.9%) |
| Mar 2023 | - | $37.84 M(+0.7%) |
| Dec 2022 | $37.57 M(+102.9%) | $37.57 M(-1.7%) |
| Sept 2022 | - | $38.23 M(+6.8%) |
| June 2022 | - | $35.79 M(+44.8%) |
| Mar 2022 | - | $24.73 M(+33.5%) |
| Dec 2021 | $18.52 M(+837.7%) | $18.52 M(+73.4%) |
| Sept 2021 | - | $10.68 M(+60.7%) |
| June 2021 | - | $6.64 M(-53.7%) |
| Mar 2021 | - | $14.34 M(+626.3%) |
| Dec 2020 | $1.98 M(-1.7%) | $1.98 M(-34.1%) |
| Sept 2020 | - | $3.00 M(+55.4%) |
| June 2020 | - | $1.93 M(+59.1%) |
| Mar 2020 | - | $1.21 M(-39.7%) |
| Dec 2019 | $2.01 M(-32.3%) | $2.01 M(+35.5%) |
| Sept 2019 | - | $1.48 M(+100.9%) |
| June 2019 | - | $738.00 K(-6.3%) |
| Mar 2019 | - | $788.00 K(-73.5%) |
| Dec 2018 | $2.97 M(+52.6%) | $2.97 M(+182.4%) |
| Sept 2018 | - | $1.05 M(-22.9%) |
| June 2018 | - | $1.36 M(-23.6%) |
| Mar 2018 | - | $1.78 M(-8.2%) |
| Dec 2017 | $1.95 M(-66.3%) | $1.95 M(+74.8%) |
| Sept 2017 | - | $1.11 M(-39.3%) |
| June 2017 | - | $1.83 M(-46.2%) |
| Mar 2017 | - | $3.41 M(-40.9%) |
| Dec 2016 | $5.77 M(+44.3%) | $5.77 M(+50.5%) |
| Sept 2016 | - | $3.83 M(+112.8%) |
| June 2016 | - | $1.80 M(-33.0%) |
| Mar 2016 | - | $2.69 M(-32.8%) |
| Dec 2015 | $4.00 M(-31.5%) | $4.00 M(+44.6%) |
| Sept 2015 | - | $2.77 M(+122.2%) |
| June 2015 | - | $1.25 M(-64.1%) |
| Mar 2015 | - | $3.47 M(-40.6%) |
| Dec 2014 | $5.84 M(+9.7%) | $5.84 M(+44.1%) |
| Sept 2014 | - | $4.05 M(+72.9%) |
| June 2014 | - | $2.34 M(-18.0%) |
| Mar 2014 | - | $2.86 M(-46.3%) |
| Dec 2013 | $5.32 M(-1.7%) | $5.32 M(+19.7%) |
| Sept 2013 | - | $4.45 M(+294.1%) |
| June 2013 | - | $1.13 M(-63.4%) |
| Mar 2013 | - | $3.08 M(-43.1%) |
| Dec 2012 | $5.41 M | $5.41 M(+29.7%) |
| Sept 2012 | - | $4.17 M(+344.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $938.00 K(-63.1%) |
| Mar 2012 | - | $2.54 M(-21.0%) |
| Dec 2011 | $3.22 M(-33.2%) | $3.22 M(-27.2%) |
| Sept 2011 | - | $4.42 M(+280.3%) |
| June 2011 | - | $1.16 M(-53.6%) |
| Mar 2011 | - | $2.51 M(-48.0%) |
| Dec 2010 | $4.82 M(+34.0%) | $4.82 M(+0.6%) |
| Sept 2010 | - | $4.79 M(+460.4%) |
| June 2010 | - | $855.00 K(-37.0%) |
| Mar 2010 | - | $1.36 M(-62.3%) |
| Dec 2009 | $3.60 M(-20.4%) | $3.60 M(+44.7%) |
| Sept 2009 | - | $2.49 M(+1527.6%) |
| June 2009 | - | $152.80 K(-91.5%) |
| Mar 2009 | - | $1.80 M(-60.3%) |
| Dec 2008 | $4.52 M(-32.0%) | $4.52 M(-17.7%) |
| Sept 2008 | - | $5.50 M(+241.0%) |
| June 2008 | - | $1.61 M(-52.3%) |
| Mar 2008 | - | $3.38 M(-49.2%) |
| Dec 2007 | $6.65 M(+1.4%) | $6.65 M(-4.5%) |
| Sept 2007 | - | $6.96 M(+305.2%) |
| June 2007 | - | $1.72 M(-37.5%) |
| Mar 2007 | - | $2.75 M(-58.1%) |
| Dec 2006 | $6.56 M(-16.8%) | $6.56 M(-2.1%) |
| Sept 2006 | - | $6.70 M(+467.6%) |
| June 2006 | - | $1.18 M(-56.0%) |
| Mar 2006 | - | $2.69 M(-65.9%) |
| Dec 2005 | $7.88 M(+23.6%) | $7.88 M(-7.6%) |
| Sept 2005 | - | $8.53 M(+425.6%) |
| June 2005 | - | $1.62 M(-50.4%) |
| Mar 2005 | - | $3.27 M(-48.7%) |
| Dec 2004 | $6.38 M(-18.9%) | $6.38 M(+60.7%) |
| Sept 2004 | - | $3.97 M(+191.4%) |
| June 2004 | - | $1.36 M(-34.4%) |
| Mar 2004 | - | $2.08 M(-73.6%) |
| Dec 2003 | $7.86 M(+87.7%) | $7.86 M(+70.9%) |
| Sept 2003 | - | $4.60 M(+155.5%) |
| June 2003 | - | $1.80 M(-11.0%) |
| Mar 2003 | - | $2.02 M(-51.7%) |
| Dec 2002 | $4.19 M(+0.3%) | $4.19 M(-1.3%) |
| Sept 2002 | - | $4.24 M(+137.8%) |
| June 2002 | - | $1.78 M(-13.2%) |
| Mar 2002 | - | $2.06 M(-50.8%) |
| Dec 2001 | $4.18 M(+2.8%) | $4.18 M(-15.1%) |
| Sept 2001 | - | $4.92 M(+261.6%) |
| June 2001 | - | $1.36 M(-37.8%) |
| Mar 2001 | - | $2.18 M(-46.2%) |
| Dec 2000 | $4.06 M(-38.4%) | $4.06 M(+6.0%) |
| Sept 2000 | - | $3.83 M(-41.9%) |
| Dec 1999 | $6.60 M | $6.60 M |
FAQ
- What is ProPhase Labs annual accounts receivable?
- What is the all time high annual accounts receivable for ProPhase Labs?
- What is ProPhase Labs annual accounts receivable year-on-year change?
- What is ProPhase Labs quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ProPhase Labs?
- What is ProPhase Labs quarterly accounts receivable year-on-year change?
What is ProPhase Labs annual accounts receivable?
The current annual accounts receivable of PRPH is $40.18 M
What is the all time high annual accounts receivable for ProPhase Labs?
ProPhase Labs all-time high annual accounts receivable is $40.18 M
What is ProPhase Labs annual accounts receivable year-on-year change?
Over the past year, PRPH annual accounts receivable has changed by +$2.61 M (+6.94%)
What is ProPhase Labs quarterly accounts receivable?
The current quarterly accounts receivable of PRPH is $31.64 M
What is the all time high quarterly accounts receivable for ProPhase Labs?
ProPhase Labs all-time high quarterly accounts receivable is $40.18 M
What is ProPhase Labs quarterly accounts receivable year-on-year change?
Over the past year, PRPH quarterly accounts receivable has changed by -$7.00 M (-18.13%)